TNF and inflammatory bowel disease: Lastly, anti-TNF inhibitors, such as infliximab, have been administered to patients with MIS-C, as they are widely used for the treatment of rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease (IBD), and refractory Kawasaki disease.